V-Unite

CASE STUDY

Client: Mayne Pharma

Category:

Date:

Overview
Mayne Pharma sought a creative solution to educate women aged 18-35 about the benefits of estrogen, specifically E4, in a way that would boost awareness and engagement. The goal was to create an innovative, engaging platform that would resonate with this demographic.
Screenshot-2024-10-17-171700
Screenshot-2024-10-17-171601
EstrogenIQ E1
EstrogenIQ E4
EstrogenIQ entrance
EstrogenIQ lobby

PROJECT BRIEF

Objectives

  1. Increase Awareness of Estetrol (E4): Create a platform to educate the audience on the benefits and unique aspects of E4, the newest FDA-approved estrogen for birth control in over 60 years.
  2. Educate on Estrogen and Hormones: Provide an interactive learning experience that explains the role of estrogen and hormones in birth control and their impact on women’s health.
  3. Boost Engagement Metrics: Enhance site engagement, track key metrics like page visits, engagement rate, conversion visits, time spent on site, and return visit rates to evaluate the platform’s effectiveness.

Success Metrics

  1. Increase Awareness of E4 and its Benefits: Through an immersive unbranded experience, Estrogen IQ aimed to boost knowledge about Estetrol and its revolutionary role in birth control products.
  2. Educational Impact: Focus on educating visitors on the role of estrogen, emphasizing the unique properties of E4 and its benefits in the Nextstellis contraceptive pill.
  3. Engagement and Interaction: Measured by visits, engagement rate, conversion rates, page views per visit, homepage bounce rate, unique visitors, and return visit rate.

V-UNITE SOLUTION

Estrogen IQ delivered an engaging, unbranded experience to help users understand the benefits of E4:

  • Interactive Learning Modules: Users were guided through engaging, visually appealing content that highlighted the role of Estetrol in birth control and its benefits over other types of estrogen.
  • Focus on Education: The platform focused on explaining how hormones, specifically estrogen, work within contraceptives, helping to simplify complex medical information for the general public.
  • Engagement Through Gamification: Quizzes and interactive exhibits allowed users to test their knowledge about E4, ensuring a more memorable and impactful learning experience.

RESULT

The Estrogen IQ initiative successfully met its objectives, with key outcomes including:

  • Increased Awareness of Estetrol (E4): The platform educated thousands of users about the benefits of E4 and its role in Nextstellis, making it a trusted source of information about this newly FDA-approved estrogen.
  • High Engagement Rates: The site saw strong engagement metrics, including higher conversion rates, longer time spent on site, and a notable number of return visits, indicating a successful educational experience.
  • Improved Knowledge Retention: Visitors left the experience with a greater understanding of how E4 works, with the platform’s quizzes and interactive features contributing to improved retention of information

Bring your event into a world full of virtual possibilities.

ENGAGE. INTERACT. GROW.

SCHEDUE DEMO